Unknown

Dataset Information

0

Carcinoembryonic Antigen (CEA)-Specific 4-1BB-Costimulation Induced by CEA-Targeted 4-1BB-Agonistic Trimerbodies.


ABSTRACT: 4-1BB (CD137) is an inducible costimulatory receptor that promotes expansion and survival of activated T cells; and IgG-based 4-1BB-agonistic monoclonal antibodies exhibited potent antitumor activity in clinical trials. However, the clinical development of those antibodies is restricted by major off-tumor toxicities associated with Fc?R interactions. We have recently generated an EGFR-targeted 4-1BB-agonistic trimerbody that demonstrated strong antitumor activity and did not induce systemic inflammatory cytokine secretion and hepatotoxicity associated with first-generation 4-1BB agonists. Here, we generate a bispecific 4-1BB-agonistic trimerbody targeting the carcinoembryonic antigen (CEA) that is highly expressed in cancers of diverse origins. The CEA-targeted anti-4-1BB-agonistic trimerbody consists of three 4-1BB-specific single-chain fragment variable antibodies and three anti-CEA single-domain antibodies positioned around a murine collagen XVIII-derived homotrimerization domain. The trimerbody was produced as a homogenous, non-aggregating, soluble protein purifiable by standard affinity chromatographic methods. The purified trimerbody was found to be trimeric in solution, very efficient at recognizing 4-1BB and CEA, and potently costimulating T cells in vitro in the presence of CEA. Therefore, trimerbody-based tumor-targeted 4-1BB costimulation is a broadly applicable and clinically feasible approach to enhance the costimulatory environment of disseminated tumor lesions.

SUBMITTER: Mikkelsen K 

PROVIDER: S-EPMC6685135 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Carcinoembryonic Antigen (CEA)-Specific 4-1BB-Costimulation Induced by CEA-Targeted 4-1BB-Agonistic Trimerbodies.

Mikkelsen Kasper K   Harwood Seandean Lykke SL   Compte Marta M   Merino Nekane N   Mølgaard Kasper K   Lykkemark Simon S   Alvarez-Mendez Ana A   Blanco Francisco J FJ   Álvarez-Vallina Luis L  

Frontiers in immunology 20190731


4-1BB (CD137) is an inducible costimulatory receptor that promotes expansion and survival of activated T cells; and IgG-based 4-1BB-agonistic monoclonal antibodies exhibited potent antitumor activity in clinical trials. However, the clinical development of those antibodies is restricted by major off-tumor toxicities associated with FcγR interactions. We have recently generated an EGFR-targeted 4-1BB-agonistic trimerbody that demonstrated strong antitumor activity and did not induce systemic infl  ...[more]

Similar Datasets

| S-EPMC4458184 | biostudies-literature
| S-EPMC6690998 | biostudies-literature
| S-EPMC4079198 | biostudies-literature
| S-EPMC5144549 | biostudies-literature
| S-EPMC7477921 | biostudies-literature
| S-EPMC3188744 | biostudies-literature
| S-EPMC5645034 | biostudies-literature
| S-EPMC6906275 | biostudies-literature
| S-EPMC3059814 | biostudies-literature
| S-EPMC6237851 | biostudies-literature